NZ336129A - Micro-particulate form of a tetrahydropyridin derivative (SR 57746) - Google Patents

Micro-particulate form of a tetrahydropyridin derivative (SR 57746)

Info

Publication number
NZ336129A
NZ336129A NZ336129A NZ33612997A NZ336129A NZ 336129 A NZ336129 A NZ 336129A NZ 336129 A NZ336129 A NZ 336129A NZ 33612997 A NZ33612997 A NZ 33612997A NZ 336129 A NZ336129 A NZ 336129A
Authority
NZ
New Zealand
Prior art keywords
micro
particulate form
tetrahydropyridin
derivative
tetrahydropyridin derivative
Prior art date
Application number
NZ336129A
Other languages
English (en)
Inventor
Antoine Caron
Jean-Pierre Chambon
Olivier Monnier
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NZ336129A publication Critical patent/NZ336129A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ336129A 1996-12-23 1997-12-23 Micro-particulate form of a tetrahydropyridin derivative (SR 57746) NZ336129A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615905A FR2757510B1 (fr) 1996-12-23 1996-12-23 Forme microparticulaire d'un derive de tetrahydropyridine
PCT/FR1997/002394 WO1998028272A1 (fr) 1996-12-23 1997-12-23 Forme microparticulaire d'un derive de tetrahydropyridine

Publications (1)

Publication Number Publication Date
NZ336129A true NZ336129A (en) 2000-11-24

Family

ID=9499044

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ336129A NZ336129A (en) 1996-12-23 1997-12-23 Micro-particulate form of a tetrahydropyridin derivative (SR 57746)

Country Status (37)

Country Link
US (4) US20020028247A1 (Sortimente)
EP (1) EP0950051B1 (Sortimente)
JP (2) JP4422214B2 (Sortimente)
KR (1) KR100455797B1 (Sortimente)
CN (1) CN1088698C (Sortimente)
AR (1) AR009673A1 (Sortimente)
AT (1) ATE250032T1 (Sortimente)
AU (1) AU730302B2 (Sortimente)
BR (1) BR9714177A (Sortimente)
CA (1) CA2275593C (Sortimente)
CO (1) CO4920213A1 (Sortimente)
CZ (1) CZ294272B6 (Sortimente)
DE (1) DE69724999T2 (Sortimente)
DK (1) DK0950051T3 (Sortimente)
DZ (1) DZ2386A1 (Sortimente)
EE (1) EE04112B1 (Sortimente)
EG (1) EG24749A (Sortimente)
ES (1) ES2207758T3 (Sortimente)
FR (1) FR2757510B1 (Sortimente)
HU (1) HU224348B1 (Sortimente)
IL (1) IL129937A (Sortimente)
IN (1) IN186977B (Sortimente)
IS (1) IS2064B (Sortimente)
MY (1) MY126298A (Sortimente)
NO (1) NO311569B1 (Sortimente)
NZ (1) NZ336129A (Sortimente)
PL (1) PL190098B1 (Sortimente)
PT (1) PT950051E (Sortimente)
RU (1) RU2193031C2 (Sortimente)
SI (1) SI0950051T1 (Sortimente)
SK (1) SK283917B6 (Sortimente)
TR (1) TR199901362T2 (Sortimente)
TW (1) TW534820B (Sortimente)
UA (1) UA66776C2 (Sortimente)
WO (1) WO1998028272A1 (Sortimente)
YU (1) YU49427B (Sortimente)
ZA (1) ZA9711579B (Sortimente)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2330642C2 (ru) * 2001-07-06 2008-08-10 Лайфсайкл Фарма А/С Регулируемая агломерация
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
RU2472490C1 (ru) * 2011-08-05 2013-01-20 Открытое акционерное общество "Биосинтез" Средство для лечения кожных гнойных инфекций, составы и способы получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US562883A (en) * 1896-06-30 Thill-coupling
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
KR100225983B1 (ko) * 1992-10-26 1999-10-15 클라우스-디터 홈메리히, 디트리히 빌헬름 샤흐트 마이크로캡슐의 제조 방법
US5662883A (en) * 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
US6489334B2 (en) * 1996-12-23 2002-12-03 Sanofi-Synthelabo Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors

Also Published As

Publication number Publication date
WO1998028272A1 (fr) 1998-07-02
AU5668598A (en) 1998-07-17
DK0950051T3 (da) 2004-01-26
HU224348B1 (hu) 2005-08-29
AU730302B2 (en) 2001-03-01
PT950051E (pt) 2004-02-27
CO4920213A1 (es) 2000-05-29
MY126298A (en) 2006-09-29
CZ229199A3 (cs) 1999-09-15
EE9900263A (et) 2000-02-15
HUP0001181A2 (hu) 2000-11-28
ATE250032T1 (de) 2003-10-15
FR2757510A1 (fr) 1998-06-26
RU2193031C2 (ru) 2002-11-20
YU49427B (sh) 2006-01-16
ES2207758T3 (es) 2004-06-01
IL129937A (en) 2002-09-12
US20020192292A1 (en) 2002-12-19
SK82999A3 (en) 1999-12-10
FR2757510B1 (fr) 2000-01-07
CZ294272B6 (cs) 2004-11-10
DE69724999D1 (de) 2003-10-23
TR199901362T2 (xx) 1999-09-21
NO993077D0 (no) 1999-06-22
NO311569B1 (no) 2001-12-10
UA66776C2 (uk) 2004-06-15
CN1088698C (zh) 2002-08-07
NO993077L (no) 1999-06-22
TW534820B (en) 2003-06-01
US20080255365A1 (en) 2008-10-16
YU28899A (sh) 2000-03-21
JP2001507013A (ja) 2001-05-29
IS2064B (is) 2005-11-15
EP0950051A1 (fr) 1999-10-20
EG24749A (en) 2010-07-20
KR100455797B1 (ko) 2004-11-06
HUP0001181A3 (en) 2003-03-28
CN1241179A (zh) 2000-01-12
DE69724999T2 (de) 2004-07-22
IS5077A (is) 1999-06-10
SK283917B6 (sk) 2004-05-04
US20100021541A1 (en) 2010-01-28
SI0950051T1 (en) 2004-02-29
CA2275593C (en) 2005-12-20
PL190098B1 (pl) 2005-10-31
AR009673A1 (es) 2000-04-26
IL129937A0 (en) 2000-02-29
HK1024000A1 (en) 2000-09-29
EE04112B1 (et) 2003-08-15
EP0950051B1 (fr) 2003-09-17
DZ2386A1 (fr) 2002-12-28
CA2275593A1 (en) 1998-07-02
BR9714177A (pt) 2000-02-29
IN186977B (Sortimente) 2001-12-22
US20020028247A1 (en) 2002-03-07
KR20000069503A (ko) 2000-11-25
JP4422214B2 (ja) 2010-02-24
PL334276A1 (en) 2000-02-14
JP2009280581A (ja) 2009-12-03
ZA9711579B (en) 1998-06-25

Similar Documents

Publication Publication Date Title
BG104511A (en) Spheroids, preparation method and pharmaceutical compositions
GEP20084461B (en) New derivative of 3,3- diphenyl-propylamine
GEP20074030B (en) Controlled synthesis of ziprasidone and compositions thereof
CY2369B1 (en) Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same.
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9901389A3 (en) Piperidine and pyrrolidine derivatives acting for the central nervous system, pharmaceutical compositions containing these compounds, preparation and use thereof
HUP9801382A3 (en) Piperazine derivatives as neurokinin antagonists and pharmaceutical compositions containing these compounds
AU5992198A (en) Novel arylpiperazine derived from piperidine as antidepressant medicines
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
AU7296696A (en) Deodorising formulations containing cationic biopolymers, aluminium chlorhydrate and esterase inhibitors
NZ336129A (en) Micro-particulate form of a tetrahydropyridin derivative (SR 57746)
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
ZA997511B (en) Novel heteroethynlene compounds and pharmaceutical and cosmetic compositions containing same.
CA2322501A1 (en) Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
HUP0204430A3 (en) Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives, the obtained new compounds and pharmaceutical compositions containing thereof
IL116826A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9900863A3 (en) 4,4-(disubstituted)cyclohexan-1-ol derivatives pharmaceutical compositions containing these compounds and use thereof
IL116747A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired